The Mediterranean, the US pharmaceutical company Gilead Sciences was originally developed for the treatment of Ebola virus disease, but never for this use approved. Later, there were indications that it might act against corona viruses. Remdesivir is administered by Infusion and inhibits an enzyme the virus for their propagation is necessary.How is the study location?
There were published several studies to Remdesivir, but many were hardly any conclusions on efficacy. In may, an international Team presented the first positive results in the "New England Journal of Medicine" ("NEJM"). About half of the 1063 subjects got Remdesivir. The other came in the control group.What success has the Remdesivir?
"We have demonstrated that the drug is a Covid-19-disease, and softens the severe progression of the disease phase is reduced to about four days," says the study involved infections Loge, Gerd Fätkenheuer of the University hospital of Cologne, the German press Agency. The patients with Remdesivir had a recovery time of 11 days, the control group of 15. Remdesivir was overall very well tolerated, says Fätkenheuer. The study reported in the control group even more side effects than in patients with Remdesivir. In both groups, people died, however, on the Coronavirus. The authors do not write in the "NEJM", the administration of antiviral agents alone would be sufficient, probably, to the therapy.
read more about the Coronavirus in the News-Ticker of FOCUS Online.there Is criticism of a marketing authorisation?
Fätkenheuer rejects the criticism: "If one reads have been 'four days less sick', one says perhaps: Well, what's the point? Makes this so much? But it is a sky is of course a difference whether someone is on the intensive and artificially ventilated, or whether he will be spared. And that can depend on this drug, such cases, we have had in the study."Who should be treated with Remdesivir?
The agent had been tested in the study, both in the case of slight as in the case of seriously ill patients, reports Fätkenheuer. The study showed that especially patients benefited at an early stage of the disease of Remdesivir.the funds Will be available in Germany?
The United States has secured a large part of the to September is the targeted production amount of Remdesivir. Germany has secured, according to the Ministry of health at an early stage Remdesivir supplies. There is currently enough reserves. He added that he expects the US manufacturer to the approval, "that Germany and Europe are supplied when it comes to such a drug," said Minister of health, Jens Spahn (CDU) on Thursday in the ZDF-"morning magazine".
the main production site of Remdesivir La Verne in California. "However, we have supplemented our own production by the significant additional capacity of several production partners in North America, Europe and Asia", explained the spokesman of Gilead, in Germany, Martin flörke Meier. Gilead have also completed license agreements with nine generic drugs manufacturers in Egypt, India and Pakistan. It had increased the production significantly, it could not be driven in the case of a large outbreak of rapidly more high.What is the cost of the drug?
A five-day treatment with Remdesivir will cost according to the company, at the time of order by the US government, 2340 dollars (about 2000 Euro) per Patient. This net amount is also planned for Germany, insured flörke Meier. The costs are paid for in Germany by the funds. The researchers Fätkenheuer criticized the prize as "extremely high". "I would expect that societal and ethical considerations play in the case of a drug like Remdesivir a role," said the infections Lodge of the "Kölner Stadt-Anzeiger". Summer Outlook: July starts wet, but then the reversal of PCP summer Outlook: July comes the wet starts, but then the turnaround CSU-Mrs decomposed AfD-request - a handkerchief, FOCUS Online/Wochit pulls out of you suddenly, "For your crocodile tears": CSU-woman decomposed AfD-request - then pulls out suddenly, a handkerchiefter/dpa Updated Date: 03 July 2020, 17:27